Amy Tucker, MD
Orthopaedic Surgery · Stow, OHNPI 1790746931
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $369,349 of the $570,530 with a category attached, or 64.7%. Organogenesis Inc. accounts for 97.9% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $120,552, 2.8 times the $42,760 reported in 2019. Among orthopaedic surgery clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 992 payments — averaging $575.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$559K
- Arthrex$6K
- Rock Medical Orthopedics, Inc.$5K
- Stryker$829
- Smith+Nephew$599
- Integra Lifesciences Corporation$139
- plus $143 from 5 others
What the payments were for
- Consulting fees$126,94722%
- Speaking & faculty fees$369,34965%
- Travel & lodging$55,41610%
- Food & beverage$12,7342%
- Education$6,0851%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 919 | $558,613 |
| Arthrex | 8 | $5,575 |
| Rock Medical Orthopedics, Inc. | 12 | $4,633 |
| Stryker | 21 | $829 |
| Smith+Nephew | 22 | $599 |
| Integra Lifesciences Corporation | 3 | $139 |
| Johnson & Johnson | 2 | $72 |
| AbbVie | 2 | $34 |
| Molnlycke Health Care US, LLC | 1 | $21 |
| Genentech USA, Inc. | 1 | $15 |
| Microaire Surgical Instruments LLC | 1 | $1 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PURAPLY WOUND MATRIX$146,600
- Apligraf$134,359
- Puraply Antimicrobial$123,505
- PuraPly$98,393
- Affinity$96,221
- NuShield$55,670
- NOVACHOR$49,644
- Dermagraft$40,533
- Puraply/Affinity/NuTech$40,533
- EVOS$261
- AUGMENT INJECTABLE$145
- TRIGEN InterTAN$137
- TENOGLIDE$130
- PANGEA$114
How this compares
$570,530 in reported general payments places this provider in the 95th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 33 | $272 |
| Silver Sulfadiazine | 14 | $126 |
| Amoxicillin | 23 | $11 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Stow
- Reuben GobezieCleveland$12M
- Gregory BerletWorthington$9.6M
- Wael BarsoumCleveland$8.9M
- Brian CohenChillicothe$8.8M
- Joseph IannottiCleveland$7.1M
- John SontichYoungstown$3.6M
- Anthony MiniaciCleveland$3.1M
- David WelkerMiamisburg$2.8M
- Kenneth GreeneCleveland$2.6M
- Mark FroimsonCleveland$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.